Development and characterization of spray-dried porous nanoaggregates for pulmonary delivery of anti-tubercular drugs

Drug Delivery

Volumn 23, Issue 3, 2016, Pages 882-887

  Kaur, Ranjot ^a   Garg, Tarun ^a   Malik, Basant ^a   Gupta, Umesh Datta ^b   Gupta, Pushpa ^b   Rath, Goutam ^a   Goyal, Amit Kumar ^a  

^a ISF COLLEGE OF PHARMACY   (India)

^b NATIONAL JALMA INSTITUTE FOR LEPROSY AND OTHER MYCOBACTERIAL DISEASES   (India)

Author keywords

Nanoaggregate; Patient compliance; Pulmonary route; Sustained release; Tuberculosis

Indexed keywords

DELAYED RELEASE FORMULATION; DRUG CARRIER; GALACTAN; GUAR GUM; ISONIAZID; MANNAN; NANOPARTICLE; PLANT GUM; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADMINISTRATION AND DOSAGE; ANIMAL; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; FEMALE; LUNG; MALE; MEDICINAL CHEMISTRY; MYCOBACTERIUM TUBERCULOSIS; POROSITY; PROCEDURES; RAT; TUBERCULOSIS; WISTAR RAT;

ANIMALS; ANTITUBERCULAR AGENTS; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; FEMALE; GALACTANS; ISONIAZID; LUNG; MALE; MANNANS; MYCOBACTERIUM TUBERCULOSIS; NANOPARTICLES; PLANT GUMS; POROSITY; RATS; RATS, WISTAR; RIFAMPIN; TUBERCULOSIS;

EID: 84958211846     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2014.920428     Document Type: Article

References (16)

1. Baum GL, Lafair J. (2003). DOTS-S: directly observed therapy short course-with smiles. Int J Tuberc Lung Dis 7: 200-1
2. Doan TV, Olivier JC. (2009). Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization. Int J Pharm 382: 61-6
3. Duret C, Wauthoz N, Merlos R, et al. (2012). In vitro and in vivo evaluation of a dry powder endotracheal insufflator device for use in dose-dependent preclinical studies in mice. Eur J Pharm Biopharm 81: 627-34
4. Gangotri W, Jain-Raina R, Babbar SB. (2012). Evaluation of guar gum derivatives as gelling agents for microbial culture media. World J Microbiol Biotechnol 28: 2279-85
5. Garg T, Singh O, Arora S, Murthy R. (2012). Scaffold: a novel carrier for cell and drug delivery. Crit Rev Ther Drug Carrier Syst 29: 1-63
6. Garg T, Singh S, Goyal AK. (2013). Stimuli-sensitive hydrogels: an excellent carrier for drug and cell delivery. Crit Rev Ther Drug Carrier Syst 30: 369-409
7. Goyal G, Garg T, Malik B, et al. (2013). Development and characterization of niosomal gel for topical delivery of benzoyl peroxide. Drug delivery
8. Hirota K, Hasegawa T, Nakajima T, et al. (2010). Delivery of rifampicin-PLGA microspheres into alveolar macrophages is promising for treatment of tuberculosis. J Control Release 142: 339-46
9. Islam N, Gladki E. (2008). Dry powder inhalers (DPIs)-A review of device reliability and innovation. Int J Pharm 360: 1-11
10. Kaur M, Garg T, Rath G, Goyal AK. (2014a). Current nanotechnological strategies for effective delivery of bioactive drug molecules in the treatment of tuberculosis. Crit Rev Ther Drug Carrier Syst 31: 49-88
11. Kaur M, Malik B, Garg T, et al. (2014b). Development and characterization of guar gum nanoparticles for oral immunization against tuberculosis. Drug delivery
12. Misra A, Hickey AJ, Rossi C, et al. (2011). Inhaled drug therapy for treatment of tuberculosis. Tuberculosis (Edinb) 91: 71-81
13. Parnami N, Garg T, Rath G, Goyal AK. (2013). Development and characterization of nanocarriers for topical treatment of psoriasis by using combination therapy. Artif Cells Nanomed Biotechnol
14. Shim TS, Jo KW. (2013). Medical treatment of pulmonary multidrug-resistant tuberculosis. Infect Chemother 45: 367-74
15. Singh H, Sharma R, Joshi M, et al. (2014). Transmucosal delivery of Docetaxel by mucoadhesive polymeric nanofibers. Artif Cells Nanomed Biotechnol. [Epub ahead of print]
16. Soumya RS, Ghosh S, Abraham ET. (2010). Preparation and characterization of guar gum nanoparticles. Int J Biol Macromol 46: 267-9